T50.A13A Poisoning by pertussis vaccine, including combinations with a pertussis component, assault, initial encounter

Name of the Condition

• Poisoning by pertussis vaccine, including combinations with a pertussis component, assault, initial encounter

Summary

This condition describes poisoning resulting from exposure to a pertussis (whooping cough) vaccine, either alone or in combination with other vaccine components, due to assault. The clinical presentation and management depend on the nature of the exposure and the individual's response to the vaccine.

Causes

Exposure occurs due to deliberate administration of the pertussis vaccine as part of an assault. The vaccine component, such as the inactivated or acellular antigen, is the primary agent involved in the toxic or adverse reaction.

Risk Factors

• Victim of physical assault or violence
• Exposure to vaccine through forced administration
• Lack of consent during vaccine administration

Symptoms

• Localized reactions at the injection site (e.g., swelling, redness, pain)
• Systemic symptoms such as fever, irritability, or malaise
• Severe reactions like allergic responses, respiratory distress, or anaphylaxis

Diagnosis

Diagnosis is based on a history of assault-related vaccine exposure, clinical evaluation of symptoms, and exclusion of other causes. Laboratory tests may be used to assess for adverse reactions or complications.

Treatment Options

Treatment focuses on managing symptoms and addressing the underlying assault. This may include antihistamines for allergic reactions, corticosteroids for inflammation, or supportive care for systemic effects. Psychological support may also be necessary.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timely intervention. Follow-up care may involve monitoring for delayed symptoms, assessing for long-term effects, and addressing any psychological impact from the assault.

Complications

• Severe allergic reactions (e.g., anaphylaxis)
• Respiratory distress or failure
• Neurological complications (e.g., seizures)
• Psychological trauma from the assault

Lifestyle & Prevention

Prevention involves ensuring safe environments and addressing violence. For healthcare providers, verifying consent and documenting vaccine administration can help mitigate risks.

When to Seek Professional Help

Seek immediate medical attention if symptoms like difficulty breathing, swelling, or severe pain occur after suspected vaccine exposure. Report the assault to appropriate authorities.

Tips for Medical Coders

Document the assault context clearly, including details of the exposure and initial encounter. Ensure the code T50.A13A is used when the poisoning is due to assault and is the initial encounter. Verify that the pertussis vaccine component is specified in the documentation.